Prometheus Announces Breakthrough e-Kerosene Pathway to Make Cost-Competitive SAF and Diesel from Electricity and Air
14.1.2026 14:57:00 CET | Business Wire | Press Release
Prometheus Fuels today announced its revolutionary new pathway for producing synthetic paraffinic kerosene (the basis for SAF jet fuel and e-diesel) from direct air capture of CO2 and off-grid renewable electricity. The new Prometheus e-kerosene pathway makes Fischer-Tropsch synthesis obsolete, reducing the cost to make e-fuels by more than 80 percent compared to the century-old technology. It is also the first process in history to make kerosene from electricity and atmospheric CO2 without using hydrogen. The kerosene produced is 100 percent carbon neutral. Two independent engineering reviews confirmed demonstration of the new pathway using commercial-scale cells.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260114310118/en/
Because the Prometheus e-kerosene pathway operates at ambient temperatures and pressures, it uses much less expensive equipment than the high-temperature, high-pressure Fischer-Tropsch process. This is just one example of several major cost drivers of conventional e-fuel production Prometheus has eliminated with its breakthrough e-kerosene pathway. ©Prometheus Fuels
The announcement follows the company’s recent milestone achievement of completing a one-year pilot-scale demonstration of its DAC-to-fuels technology platform, producing e-methanol at its Titan Forge Alpha pilot facility. The pilot and its operating data were validated by two independent engineering reviews, in November and December of 2025.
For the first time, Prometheus is releasing details of its new 100 percent electrochemical synthetic paraffinic kerosene pathway, which uses CO2 captured from the air using the company’s proprietary “No-Desorb DAC” process. A key breakthrough that made the new kerosene pathway possible is a process the company calls “electrochemical oligomerization.” Oligomerization is the combining of smaller monomers into larger molecules, like hydrocarbons. One example of this is carbon-carbon chain lengthening. In the Fischer-Tropsch process, this chain lengthening occurs due to the high pressures and temperatures that process requires. It is these extreme operating conditions, which require expensive equipment and 24-7, grid-connected power, that keep the cost of Fischer-Tropsch e-fuels permanently high. In contrast, Prometheus has developed the ability to achieve its carbon-carbon chain lengthening using electromagnetic fields and electric currents in water at room temperature and atmospheric pressure. With these ambient operating conditions, the Prometheus process uses equipment that is much less expensive and can be powered by intermittent, off-grid solar, allowing access to the lowest energy input costs.
The new pathway eliminates the major cost drivers of conventional e-fuels systems. It does not desorb CO2 into a pure gas stream; does not use hydrogen; does not rely on high-temperature or high-pressure reactors; and was purpose-built to operate on intermittent off-grid renewable electricity – the cheapest electrons in the world – avoiding the high cost and geographic constraints of being connected to a grid. There is also no need for distillation. Kerosene forms directly in Prometheus’ Faraday Reactor hydrocarbon electrolyzer and self-separates from water, at room temperature and atmospheric pressure, producing finished kerosene fuel. Notably, the Prometheus e-kerosene pathway has linear cost scaling, allowing it to achieve its low costs across a wide range of production scales, from pilot systems to commercial plants.
“Our new kerosene pathway takes e-fuels beyond decarbonization to direct economic competition with oil-based fuels,” said Rob McGinnis, founder and CEO of Prometheus. “Our pathway puts three holy grails of energy within reach: a new source of energy for data centers, limitless low-cost SAF, and unblockadeable fuel logistics for defense. The implications of this new technology – the advantages it creates for energy independence and national security – are profound.”
Until now, Prometheus had shared only high-level descriptions of its technology while it focused on building and securing its patent and trade secret portfolio. With its IP portfolio secure, Prometheus is able to release more details about its technology and competitive advantages in global commodity energy markets.
About Prometheus Fuels
Prometheus is the global leader in fuels made from air and electricity to power AI data centers, factories, ships, vehicles, and aircraft. The company’s patented technology produces carbon neutral fuels that are cost-competitive with commodity fossil fuel prices without subsidies. Designed to run off-grid, Prometheus offers an infinitely scalable source of new energy, transforming intermittent renewable electricity into firm dispatchable 24/7 power, anywhere it is needed. Backed by top-tier investors including Maersk, BMW, and Y Combinator, Prometheus is redefining the future of energy. Learn more at prometheusfuels.com and prometheusfuels.AI.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260114310118/en/
Contacts
Media Contact
Amanda Martinez for Prometheus Fuels: press@prometheusfuels.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Kerecis Drives the Fish-Skin Conversation at Leading European Wound Conference - EWMA-DEWU 20264.5.2026 20:25:00 CEST | Press Release
Kerecis, the company pioneering the use of sustainably sourced intact fish skin in cellular therapy and tissue regeneration, will play a prominent scientific and educational role at the EWMA‑DEWU 2026 Conference, taking place May 6–8 at the Messe & Congress Centrum Bremen in Bremen, Germany. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260504487743/en/ MariCell® Solid This year, The European Wound Management Association's (EWMA) meeting is held in conjunction with the Deutscher Wundkongress (DEWU); combining two major wound-care congresses into a single forum for scientific exchange, education, and clinical discussion. At this year’s conference, Kerecis will highlight growing clinical experience with intact fish‑skin grafts across a broad range of wound indications, supported by two Kerecis‑led scientific symposia, multiple oral and poster presentations, and direct engagement with clinicians at Booth D30, located adjacent
Printing the Future of Medicine: CTIBIOTECH™ Announces $27 Million Investment to Launch U.S. Operations at the SelectUSA Investment Summit4.5.2026 20:00:00 CEST | Press Release
CTIBIOTECH™, a pioneering Contract Research, Development, and Manufacturing Organization (CRDMO) and global leader in 3D bioprinting of human tissues, today officially announces the launch of its North American subsidiary, CTIBIOTECH USA™. The official launch took place today at the prestigious SelectUSA Investment Summit in Washington, D.C. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260504107996/en/ From Biopsy to Breakthrough, CTIBIOTECH USA™'s Vision for Precision Medicine Operating from its new United States base in the thriving life sciences “Cellicon Valley” hub of Philadelphia, Pennsylvania, in association with BioLabs for Advanced Therapeutics, CTIBIOTECH USA™ will provide the company's proprietary human cell and tissue bioassays and New Approach Methods (NAMs) directly to North American pharmaceutical, biomedical, and dermatocosmetics markets. By producing and supplying these cutting-edge human bioassays domesti
Kubota Vision Inc. Signs Supply and Licensing Agreement with Laboratoires KÔL for Stargardt Disease Treatment Candidate Under Compassionate Use4.5.2026 17:16:00 CEST | Press Release
Kubota Vision Inc. (“Kubota Vision”), a wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Minato-ku, Tokyo, Japan) announced signing of a Supply and Licensing Agreement with Laboratoires KÔL (Clermont-Ferrand, France) for the provision of a Stargardt disease (STGD1) treatment candidate under compassionate use authorization. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260414590785/en/ The purpose of this Agreement is for Kubota Vision and KÔL to collaborate on providing “Emixustat” for treatment of Stargardt Disease (STGD1) through compassionate use authorization in France. Kubota Vision will exclusively manufacture and supply Emixustat final products to KÔL and KÔL will have exclusive rights to distribute Emixustat in France under compassionate use access. Ryo Kubota, Chairman, President, and CEO of Kubota Pharmaceutical Holdings, stated, “We are extremely pleased to enter into this Agreement with Labor
Incentive Market Set to Surpass $80B by 2030s — IMA Launches Tools to Help the Industry Keep Pace4.5.2026 16:28:00 CEST | Press Release
With combined business spend on loyalty, employee recognition, and channel incentives projected to exceed $80 billion by the 2030s, the incentive industry is entering a period of rapid scale and strategic pressure. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260422729016/en/ In response, the Incentive Marketing Association (IMA) launched a new suite of resources designed to help incentive professionals navigate an environment that’s becoming more specialized, fragmented, and central to business performance. “It’s not just more money coming in—it’s more complexity,” said Vince Chiofolo, President of the Incentive & Engagement Solution Providers (IESP). “Buyers are demanding programs that evolve fast, integrate deeply, and feel personal at scale. These new tools were built for that.” IMA’s Suite of Tools Includes: New Industry Report — Inside the Incentive Buyer’s Mind Drawn from insights of 50+ program owners, the report f
Tigo Energy Breaks Global Growth Benchmark; Boosts U.S. Energy Feature in Predict+4.5.2026 15:00:00 CEST | Press Release
Tigo Energy, Inc. (NASDAQ: TYGO) (“Tigo” or “Company”), a leading provider of intelligent solar and energy solutions, today announced that the Predict+ platform now offers integrated real-time spot market pricing for ISO customers in the United States. Predict+ provides utilities with deep insights into grid demand, renewable generation, and energy market dynamics, enhancing the precision, scalability, and robustness of energy forecasting to up to 97.5% accuracy through machine learning and artificial intelligence. For energy providers, Predict+ helps streamline operations, reduce volatility, and maximize performance. Predict+ empowers utility operators to adapt to real-world demand challenges when balancing renewable and baseload generation sources, particularly during extreme weather events and market disruptions. On the demand side, with smart meter integration, Predict+ models each meter individually and performs extensive calculations on actual, historical, and average data to acc
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom